Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Terri H. Beaty is active.

Publication


Featured researches published by Terri H. Beaty.


Science | 1996

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.

Jeffrey R. Smith; Diha Freije; John D. Carpten; Henrik Grönberg; Jianfeng Xu; Sarah D. Isaacs; Michael J. Brownstein; G. Steven Bova; Hong Guo; Piroska Bujnovszky; Deborah Nusskern; Jan-Erik Damber; Anders Bergh; Monika Emanuelsson; Olli Kallioniemi; Jennifer Walker-Daniels; Joan E. Bailey-Wilson; Terri H. Beaty; Deborah A. Meyers; Patrick C. Walsh; Francis S. Collins; Jeffrey M. Trent; William B. Isaacs

Despite its high prevalence, very little is known regarding genetic predisposition to prostate cancer. A genome-wide scan performed in 66 high-risk prostate cancer families has provided evidence of linkage to the long arm of chromosome 1 (1q24-25). Analysis of an additional set of 25 North American and Swedish families with markers in this region resulted in significant evidence of linkage in the combined set of 91 families. The data provide strong evidence of a major prostate cancer susceptibility locus on chromosome 1.


Nature Reviews Genetics | 2011

Cleft lip and palate: understanding genetic and environmental influences

Michael J. Dixon; Mary L. Marazita; Terri H. Beaty; Jeffrey C. Murray

Clefts of the lip and/or palate (CLP) are common birth defects of complex aetiology. CLP can occur in isolation or as part of a broad range of chromosomal, Mendelian or teratogenic syndromes. Although there has been marked progress in identifying genetic and environmental triggers for syndromic CLP, the aetiology of the more common non-syndromic (isolated) forms remains poorly characterized. Recently, using a combination of epidemiology, careful phenotyping, genome-wide association studies and analysis of animal models, several distinct genetic and environmental risk factors have been identified and confirmed for non-syndromic CLP. These findings have advanced our understanding of developmental biology and created new opportunities for clinical translational research.


Journal of Clinical Investigation | 1999

Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α

Aimee Y. Yu; Larissa A. Shimoda; Narayan V. Iyer; David L. Huso; Xing Sun; Rita McWilliams; Terri H. Beaty; James S K Sham; Charles M. Wiener; J. T. Sylvester; Gregg L. Semenza

Chronic hypoxia induces polycythemia, pulmonary hypertension, right ventricular hypertrophy, and weight loss. Hypoxia-inducible factor 1 (HIF-1) activates transcription of genes encoding proteins that mediate adaptive responses to hypoxia, including erythropoietin, vascular endothelial growth factor, and glycolytic enzymes. Expression of the HIF-1alpha subunit increases exponentially as O2 concentration is decreased. Hif1a-/- mouse embryos with complete deficiency of HIF-1alpha due to homozygosity for a null allele at the Hif1a locus die at midgestation, with multiple cardiovascular malformations and mesenchymal cell death. Hif1a+/- heterozygotes develop normally and are indistinguishable from Hif1a+/+ wild-type littermates when maintained under normoxic conditions. In this study, the physiological responses of Hif1a+/- and Hif1a+/+ mice exposed to 10% O2 for one to six weeks were analyzed. Hif1a+/- mice demonstrated significantly delayed development of polycythemia, right ventricular hypertrophy, pulmonary hypertension, and pulmonary vascular remodeling and significantly greater weight loss compared with wild-type littermates. These results indicate that partial HIF-1alpha deficiency has significant effects on multiple systemic responses to chronic hypoxia.


Nature Genetics | 2011

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

Dara G. Torgerson; Elizabeth J. Ampleford; Grace Y. Chiu; W. James Gauderman; Christopher R. Gignoux; Penelope E. Graves; Blanca E. Himes; A. Levin; Rasika A. Mathias; Dana B. Hancock; James W. Baurley; Celeste Eng; Debra A. Stern; Juan C. Celedón; Nicholas Rafaels; Daniel Capurso; David V. Conti; Lindsey A. Roth; Manuel Soto-Quiros; Alkis Togias; Xingnan Li; Rachel A. Myers; Isabelle Romieu; David Van Den Berg; Donglei Hu; Nadia N. Hansel; Ryan D. Hernandez; Elliott Israel; Muhammad T. Salam; Joshua M Galanter

Asthma is a common disease with a complex risk architecture including both genetic and environmental factors. We performed a meta-analysis of North American genome-wide association studies of asthma in 5,416 individuals with asthma (cases) including individuals of European American, African American or African Caribbean, and Latino ancestry, with replication in an additional 12,649 individuals from the same ethnic groups. We identified five susceptibility loci. Four were at previously reported loci on 17q21, near IL1RL1, TSLP and IL33, but we report for the first time, to our knowledge, that these loci are associated with asthma risk in three ethnic groups. In addition, we identified a new asthma susceptibility locus at PYHIN1, with the association being specific to individuals of African descent (P = 3.9 × 10−9). These results suggest that some asthma susceptibility loci are robust to differences in ancestry when sufficiently large samples sizes are investigated, and that ancestry-specific associations also contribute to the complex genetic architecture of asthma.


COPD: Journal of Chronic Obstructive Pulmonary Disease | 2011

Genetic Epidemiology of COPD (COPDGene) Study Design

Elizabeth A. Regan; John E. Hokanson; James Murphy; Barry J. Make; David A. Lynch; Terri H. Beaty; Douglas Curran-Everett; Edwin K. Silverman; James D. Crapo

ABSTRACT Background: COPDGene is a multicenter observational study designed to identify genetic factors associated with COPD. It will also characterize chest CT phenotypes in COPD subjects, including assessment of emphysema, gas trapping, and airway wall thickening. Finally, subtypes of COPD based on these phenotypes will be used in a comprehensive genome-wide study to identify COPD susceptibility genes. Methods/Results: COPDGene will enroll 10,000 smokers with and without COPD across the GOLD stages. Both Non-Hispanic white and African-American subjects are included in the cohort. Inspiratory and expiratory chest CT scans will be obtained on all participants. In addition to the cross-sectional enrollment process, these subjects will be followed regularly for longitudinal studies. A genome-wide association study (GWAS) will be done on an initial group of 4000 subjects to identify genetic variants associated with case-control status and several quantitative phenotypes related to COPD. The initial findings will be verified in an additional 2000 COPD cases and 2000 smoking control subjects, and further validation association studies will be carried out. Conclusions: COPDGene will provide important new information about genetic factors in COPD, and will characterize the disease process using high resolution CT scans. Understanding genetic factors and CT phenotypes that define COPD will potentially permit earlier diagnosis of this disease and may lead to the development of treatments to modify progression.


PLOS Genetics | 2009

Sensitive Detection of Chromosomal Segments of Distinct Ancestry in Admixed Populations

Alkes L. Price; Arti Tandon; Nick Patterson; Kathleen C. Barnes; Nicholas Rafaels; Ingo Ruczinski; Terri H. Beaty; Rasika A. Mathias; David Reich; Simon Myers

Identifying the ancestry of chromosomal segments of distinct ancestry has a wide range of applications from disease mapping to learning about history. Most methods require the use of unlinked markers; but, using all markers from genome-wide scanning arrays, it should in principle be possible to infer the ancestry of even very small segments with exquisite accuracy. We describe a method, HAPMIX, which employs an explicit population genetic model to perform such local ancestry inference based on fine-scale variation data. We show that HAPMIX outperforms other methods, and we explore its utility for inferring ancestry, learning about ancestral populations, and inferring dates of admixture. We validate the method empirically by applying it to populations that have experienced recent and ancient admixture: 935 African Americans from the United States and 29 Mozabites from North Africa. HAPMIX will be of particular utility for mapping disease genes in recently admixed populations, as its accurate estimates of local ancestry permit admixture and case-control association signals to be combined, enabling more powerful tests of association than with either signal alone.


Nature Genetics | 2010

A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4

Terri H. Beaty; Jeffrey C. Murray; Mary L. Marazita; Ronald G. Munger; Ingo Ruczinski; Jacqueline B. Hetmanski; Kung Yee Liang; Tao Wu; Tanda Murray; M. Daniele Fallin; Richard Redett; Gerald V. Raymond; Holger Schwender; Sheng Chih Jin; Margaret E. Cooper; Martine Dunnwald; Maria Adela Mansilla; Elizabeth J. Leslie; Stephen Bullard; Andrew C. Lidral; Lina M. Moreno; Renato Menezes; Alexandre R. Vieira; Aline Petrin; Allen J. Wilcox; Rolv T. Lie; Ethylin Wang Jabs; Yah Huei Wu-Chou; Philip Kuo-Ting Chen; Hong Wang

Case-parent trios were used in a genome-wide association study of cleft lip with and without cleft palate. SNPs near two genes not previously associated with cleft lip with and without cleft palate (MAFB, most significant SNP rs13041247, with odds ratio (OR) per minor allele = 0.704, 95% CI 0.635–0.778, P = 1.44 × 10−11; and ABCA4, most significant SNP rs560426, with OR = 1.432, 95% CI 1.292–1.587, P = 5.01 × 10−12) and two previously identified regions (at chromosome 8q24 and IRF6) attained genome-wide significance. Stratifying trios into European and Asian ancestry groups revealed differences in statistical significance, although estimated effect sizes remained similar. Replication studies from several populations showed confirming evidence, with families of European ancestry giving stronger evidence for markers in 8q24, whereas Asian families showed stronger evidence for association with MAFB and ABCA4. Expression studies support a role for MAFB in palatal development.


The Journal of Allergy and Clinical Immunology | 2011

Tight junction defects in patients with atopic dermatitis.

Anna De Benedetto; Nicholas Rafaels; Laura Y. McGirt; Andrei I. Ivanov; Steve N. Georas; Chris Cheadle; Alan E. Berger; Kunzhong Zhang; Sadasivan Vidyasagar; Takeshi Yoshida; Mark Boguniewicz; Tissa Hata; Lynda C. Schneider; Jon M. Hanifin; Richard L. Gallo; Natalija Novak; Stephan Weidinger; Terri H. Beaty; Donald Y.M. Leung; Kathleen C. Barnes; Lisa A. Beck

BACKGROUND Atopic dermatitis (AD) is characterized by dry skin and a hyperactive immune response to allergens, 2 cardinal features that are caused in part by epidermal barrier defects. Tight junctions (TJs) reside immediately below the stratum corneum and regulate the selective permeability of the paracellular pathway. OBJECTIVE We evaluated the expression/function of the TJ protein claudin-1 in epithelium from AD and nonatopic subjects and screened 2 American populations for single nucleotide polymorphisms in the claudin-1 gene (CLDN1). METHODS Expression profiles of nonlesional epithelium from patients with extrinsic AD, nonatopic subjects, and patients with psoriasis were generated using Illuminas BeadChips. Dysregulated intercellular proteins were validated by means of tissue staining and quantitative PCR. Bioelectric properties of epithelium were measured in Ussing chambers. Functional relevance of claudin-1 was assessed by using a knockdown approach in primary human keratinocytes. Twenty-seven haplotype-tagging SNPs in CLDN1 were screened in 2 independent populations with AD. RESULTS We observed strikingly reduced expression of the TJ proteins claudin-1 and claudin-23 only in patients with AD, which were validated at the mRNA and protein levels. Claudin-1 expression inversely correlated with T(H)2 biomarkers. We observed a remarkable impairment of the bioelectric barrier function in AD epidermis. In vitro we confirmed that silencing claudin-1 expression in human keratinocytes diminishes TJ function while enhancing keratinocyte proliferation. Finally, CLDN1 haplotype-tagging SNPs revealed associations with AD in 2 North American populations. CONCLUSION Collectively, these data suggest that an impairment in tight junctions contributes to the barrier dysfunction and immune dysregulation observed in AD subjects and that this may be mediated in part by reductions in claudin-1.


Nature Genetics | 2010

Variants in FAM13A are associated with chronic obstructive pulmonary disease

Michael H. Cho; Nadia Boutaoui; Barbara J. Klanderman; Jody S. Sylvia; John Ziniti; Craig P. Hersh; Dawn L. DeMeo; Gary M. Hunninghake; Augusto L. Litonjua; David Sparrow; Christoph Lange; Sungho Won; James Murphy; Terri H. Beaty; Elizabeth A. Regan; Barry J. Make; John E. Hokanson; James D. Crapo; Xiangyang Q. Kong; Wayne H. Anderson; Ruth Tal-Singer; David Lomas; Per Bakke; Amund Gulsvik; Sreekumar G. Pillai; Edwin K. Silverman

We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD) in three population cohorts, including 2,940 cases and 1,380 controls who were current or former smokers with normal lung function. We identified a new susceptibility locus at 4q22.1 in FAM13A and replicated this association in one case-control group (n = 1,006) and two family-based cohorts (n = 3,808) (rs7671167, combined P = 1.2 × 10−11, combined odds ratio in case-control studies 0.76, 95% confidence interval 0.69–0.83).


Journal of Immunology | 2000

Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES

Renate Nickel; Vincenzo Casolaro; Ulrich Wahn; Kirsten Beyer; Kathleen C. Barnes; Beverly Plunkett; Linda R. Freidhoff; Claudia Sengler; James R. Plitt; Robert P. Schleimer; Luis Caraballo; Raana P Naidu; Paul N. Levett; Terri H. Beaty; Shau Ku Huang

Up-regulation of C-C chemokine expression characterizes allergic inflammation and atopic diseases. A functional mutation in the proximal promoter of the RANTES gene has been identified, which results in a new consensus binding site for the GATA transcription factor family. A higher frequency of this allele was observed in individuals of African descent compared with Caucasian subjects (p < 0.00001). The mutant allele was associated with atopic dermatitis in children of the German Multicenter Allergy Study (MAS-90; p < 0.037), but not with asthma. Transient transfections of the human mast cell line HMC-1 and the T cell line Jurkat with reporter vectors driven by either the mutant or wild-type RANTES promoter showed an up to 8-fold higher constitutive transcriptional activity of the mutant promoter. This is the first report to our knowledge of a functional mutation in a chemokine gene promoter. Our findings suggest that the mutation contributes to the development of atopic dermatitis. Its potential role in other inflammatory and infectious disorders, particularly among individuals of African ancestry, remains to be determined.

Collaboration


Dive into the Terri H. Beaty's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ingo Ruczinski

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edwin K. Silverman

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael H. Cho

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan F. Scott

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge